Piperazine

Piperazine

SCHEMBL7690

C1CNCCN1.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL3062535 1.00 HIF1A (0.86)
Hydrochloric Acid SCHEMBL16226020 1.00 HIF1A (0.86)
Hydrochloric Acid SCHEMBL4769861 1.00 HIF1A (0.86)
Hydrochloric Acid SCHEMBL11801121 1.00 HIF1A (0.86)
Piperazine SCHEMBL282455 1.00
Piperazine SCHEMBL20258219 1.00 HIF1A (0.86)
Hydrochloric Acid SCHEMBL11707528 1.00 HIF1A (0.86)
Piperazine SCHEMBL6598522 1.00 HIF1A (0.86)
Piperazine SCHEMBL4467850 1.00
Hydrochloric Acid SCHEMBL5568840 1.00 HIF1A (0.86)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118028873-A D is used as2Method for preparing deuterated piperazine by using O as deuterium source through electrocatalytic effect 天津大学 2024-05-14 CN claimed
WO-2023166975-A1 PEPTIDE COMPOUND PRODUCTION METHOD 国立大学法人徳島大学 2023-09-07 WO claimed
CN-113176253-B Occult blood indicator for animal excrement and application thereof 上海麦可信生物科技有限公司 2023-05-23 CN claimed
CN-116143724-A Preparation method and application of piperazine chloride 中国科学院宁波材料技术与工程研究所 2023-05-23 CN claimed
CN-115557902-A Preparation method of N- (2-pyrimidine) piperazine hydrochloride 武汉海特生物创新医药研究有限公司 2023-01-03 CN claimed
CN-113501796-B Aminoethylated piperazine and preparation method thereof 大连理工大学 2022-08-26 CN claimed
CN-110606830-B Method for producing piperaquine phosphate intermediate quinoline piperazine hydrochloride by applying piperazine 珠海润都制药股份有限公司 2022-03-18 CN claimed
CN-109962289-B Electrolyte composition and metal ion battery comprising same 财团法人工业技术研究院 2022-03-11 CN claimed
CN-113501796-A Aminoethylated piperazine and preparation method thereof 大连理工大学 2021-10-15 CN claimed
CN-113176253-A Animal excrement occult blood indicator and application thereof 上海麦可信生物科技有限公司 2021-07-27 CN claimed
CN-1944404-A Indolyl alkyl-amine compounds and their preparing method and use in medicine production CHINA UNIV OF PHARMACY (CN) 2007-04-11 CN claimed
WO-2006064015-A2 DIPHENYLUREA DERIVATIVES USEFUL AS POTASSIUM CHANNEL ACTIVATORS NEUROSEARCH A/S (DK) 2006-06-22 WO claimed
CN-1227241-C Having 5-hydroxytryptamine 1AReceptor-active arylpiperazines LILLY CO ELI (US) 2005-11-16 CN claimed
US-6955814-B1 protecting and/or preserving organs, in particular the heart during open-heart surgery, cardiovascular diagnosis or therapeutic intervention by administering potassium channel opener or agonist and adenosine receptor agonist and local anesthetic GLOBAL CARDIAC SOLUTIONS PTY LTD. (AU) 2005-10-18 US claimed
CN-1469863-A Crystalline forms of 1- [ 6-chloro-5- (trifluoromethyl) -2-pyridinyl ] piperazine hydrochloride ��˹��ŵ�� 2004-01-21 CN claimed
CN-1399654-A Process for the preparation of coating, coated substrate, adhesive, film or sheet, for the thus obtained products and the coating mixture to be used in the process STAHL INT BV (NL) 2003-02-26 CN claimed
CN-1344135-A Organ arrest, protection and preservation UNIV JAMES COOK (AU) 2002-04-10 CN claimed
CN-1308629-A Reduced partide size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl] piperazine ZENECA ZENECA AB (SE) 2001-08-15 CN claimed
CN-1290258-A Aryl piperazine compounds with 5-hydroxytryptamine 1A receptor activity LILLY CO ELI (US) 2001-04-04 CN claimed
WO-1997022638-A1 COMPOSITIONS AND PROCESSES FOR TREATING SUBTERRANEAN FORMATIONS PHILLIPS PETROLEUM COMPANY (US) 1997-06-26 WO claimed